2.93

1.18% -0.04

Cardiff Oncology Inc (CRDF)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Cardiff Oncology Inc stock is traded at $2.93, with a volume of 278.38K. It is down -1.18% in the last 24 hours and up +0.86% over the past month. Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.

Previous Close:

$2.97

Open:

$2.96

24h Volume:

278.38K

Relative Volume:

0.32

Market Cap:

$197.37M

Revenue:

$488.00K

Net Income/Loss:

$-41.44M

P/E Ratio:

-3.1505

EPS:

-0.93

Net Cash Flow:

$-31.47M

1W Performance:

+1.91%

1M Performance:

+0.86%

6M Performance:

-31.59%

1Y Performance:

-16.14%

1-Day Range:

$2.90

$3.05

1-Week Range:

$2.72

$3.05

52-Week Range:

$1.90

$4.99

Cardiff Oncology Inc Stock (CRDF) Company Profile

Name

Cardiff Oncology Inc

Sector

Healthcare (1119)

Industry

Biotechnology (625)

Phone

858-952-7570

Address

11055 FLINTKOTE AVENUE, SAN DIEGO, CA

Employee

Twitter

@cardiffoncology

Next Earnings Date

2024-10-31

Latest SEC Filings

CRDF's Discussions on Twitter

Compare CRDF with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CRDF Cardiff Oncology Inc	2.93	200.06M	488.00K	-41.44M	-31.47M	-0.93
VRTX Vertex Pharmaceuticals Inc	466.01	118.58B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	751.87	79.40B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	815.87	51.18B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	362.61	48.88B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	339.31	37.49B	4.98B	69.59M	525.67M	0.5197

Cardiff Oncology Inc Stock (CRDF) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-05-26	Initiated	Noble Capital Markets	Outperform
Jul-08-25	Initiated	Ladenburg Thalmann	Buy
Jun-24-25	Initiated	Jefferies	Hold
Sep-06-24	Initiated	Craig Hallum	Buy
Jan-05-22	Initiated	William Blair	Outperform
Dec-08-21	Initiated	Robert W. Baird	Outperform
Aug-09-21	Resumed	Maxim Group	Buy
Oct-22-20	Initiated	H.C. Wainwright	Buy
Oct-08-20	Initiated	Piper Sandler	Overweight

View All

Cardiff Oncology Inc Stock (CRDF) Latest News

Jan 22, 2026

3 Promising Penny Stocks With Market Caps Below $600M - simplywall.st

Jan 22, 2026

Jan 20, 2026

How Cardiff Oncology Inc. stock benefits from tech adoptionMorning Star Patterns & Free Long-Term Investment Planning - bollywoodhelpline.com

Jan 20, 2026

Jan 19, 2026

Gains Recap: Should you buy the dip on Cardiff Oncology Inc2025 Bull vs Bear & Weekly High Return Forecasts - baoquankhu1.vn

Jan 19, 2026

Will Cardiff Oncology Inc. benefit from sector rotationJuly 2025 Snapshot & Safe Entry Trade Reports - bollywoodhelpline.com

Jan 19, 2026

Jan 18, 2026

What hedge fund moves indicate for Cardiff Oncology Inc. (XE7C) stock2025 Sector Review & Weekly Setup with ROI Potential - bollywoodhelpline.com

Jan 18, 2026

Jan 14, 2026

Cardiff Oncology, Inc. (NASDAQ:CRDF) Receives $11.13 Consensus Price Target from Brokerages - Defense World

Jan 14, 2026

Jan 13, 2026

Cardiff Oncology: What Storms Can We Expect In 2026? The Case For Measured Enthusiasm (NASDAQ:CRDF) - Seeking Alpha

Jan 13, 2026

Jan 11, 2026

Cardiff Oncology, Inc. (NASDAQ:CRDF) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Jan 11, 2026

Jan 08, 2026

Is Cardiff Oncology Inc. stock a buy for dividend growthJuly 2025 Action & Long Hold Capital Preservation Tips - Улправда

Jan 08, 2026

Aug Wrap: How Cardiff Oncology Inc XE7C stock reacts to Fed tightening2025 Breakouts & Breakdowns & Fast Gain Stock Tips - Bộ Nội Vụ

Jan 08, 2026

How Cardiff Oncology Inc. (XE7C) stock reacts to Fed tighteningRisk Management & Stepwise Swing Trade Plans - Улправда

Jan 08, 2026

Equities Analysts Issue Forecasts for CRDF Q4 Earnings - Defense World

Jan 08, 2026

Jan 07, 2026

Can Cardiff Oncology Inc. stock double in next 5 yearsDividend Growth Stocks & Today’s Picks, Tomorrow’s Winners - ulpravda.ru

Jan 07, 2026

Cardiff Oncology stock initiated with Outperform rating by Noble Capital - Investing.com Australia

Jan 05, 2026

Noble Financial Initiates Coverage on Cardiff Oncology (NASDAQ:CRDF) - MarketBeat

Jan 05, 2026

Dec 24, 2025